Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 10Pancreatic Neoplasms 4Neoplasms 4Lung Neoplasms 4Hematologic Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Sarcoma 2Recurrence 2Rectal Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Multiple Myeloma 2Melanoma 2Uterine Cervical Neoplasms 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Radiodermatitis 1Papillomavirus Infections 1Ovarian Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Monoclonal Gammopathy of Undetermined Significance 1Lymphoma, Mantle-Cell 1Lymphedema 1Localized Prostate Carcinoma 1

Interventions

Blood Specimen Collection 3veliparib 2Surveys and Questionnaires 2Counseling 2Carboplatin 2Zoledronic Acid 1Videotape Recording 1Telemedicine 1Taxes 1Tamoxifen 1Standard of Care 1Specimen Handling 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Palliative Care 1Paclitaxel 1Letrozole 1Genotype 1Genetic Counseling 1Exercise Test 1Echocardiography 1Early Intervention, Educational 1Docetaxel 1Diet, Mediterranean 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hereditary Breast and Ovarian Cancer Syndrome × Practice Guidelines as Topic × Clear all
NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡